AdnaTest CTC Select

An immunomagnetic enrichment solution from QIAGEN for the isolation of circulating tumour cells (CTCs) from human whole blood. The product is intended for downstream molecular characterisation within clinical research workflows.

Designed to integrate with molecular assays, the kit supports the sensitive detection and profiling of rare tumour cells recovered from blood samples. It forms the enriched CTC isolation step within QIAGEN's circulating tumour cell analysis portfolio, supplying the enriched cell population used prior to subsequent gene-expression and characterisation assays.